Location of Repository

Modelling the hepatitis B vaccination programme in prisons \ud

By A. J. Sutton, N. J. Gay, W. John Edmunds, Nicholas J. Andrews, V. D. Hope, R. L. Gilbert, M. Piper and O. N. Gill

Abstract

A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introduced into selected prisons in England and Wales. Over the coming years it is anticipated this vaccination programme will be extended. A model has been developed to assess the potential impact of the programme on the vaccination coverage of prisoners, ex-prisoners, and injecting drug users (IDUs). Under a range of coverage scenarios, the model predicts the change over time in the vaccination status of new entrants to prison, current prisoners and IDUs in the community. The model predicts that at baseline in 2012 57% of the IDU population will be vaccinated with up to 72% being vaccinated depending on the vaccination scenario implemented. These results are sensitive to the size of the IDU population in England and Wales and the average time served by an IDU during each prison visit. IDUs that do not receive HBV vaccine in the community are at increased risk from HBV infection. The HBV vaccination programme in prisons is an effective way of vaccinating this hard-to-reach population although vaccination coverage on prison reception must be increased to achieve this

Topics: RA0421, HV
Publisher: Cambridge University Press
Year: 2005
OAI identifier: oai:wrap.warwick.ac.uk:710

Suggested articles

Preview

Citations

  1. (2001). Criminal careers of those born between 1953 and 1978, England and Wales.
  2. (2002). Drug use and initiation in prison: results from a national prison Hepatitis B vaccination in prison 241survey in England and Wales. Addiction doi
  3. Drugs and crime: the results of the second developmental stage of the NEW-ADAM programme, doi
  4. (1989). Generalized linear models (Monographs on Statisitics and Applied Probability). doi
  5. (2002). Hepatitis B vaccination: how to reach risk groups. Vaccine doi
  6. Home Office. Home Office Research Study; doi
  7. (2000). Injecting drug users in Edinburgh have a high rate of recidivism. Addiction
  8. (2003). Laboratory reports of hepatitis B in England and Wales. Commun Dis Rep CDR Rev
  9. Modelling the characteristics of the males injecting drug user population in England and Wales. Inter J Drug Policy doi
  10. Population Estimates 2000. England and Wales. doi
  11. (2000). Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health
  12. (2001). Prison Health Newsletter
  13. Prison Statistics England and doi
  14. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and Hepatitis Infections in the United Kingdom 2001:Annual Report ofthe Unlinked Anonymous Prevalence Monitoring Programme. Department of Health.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.